Lactobacillus reuteri 6475 (Lr) of the human microbiome synthesizes histamine and can suppress inflammation via type 2 histamine receptor (H2R) activation in the mammalian intestine. Gut microbes such as Lr promote H2R signaling and may suppress H1R proinflammatory signaling pathways in parallel by unknown mechanisms. In this study, we identified a soluble bacterial enzyme known as diacylglycerol kinase (Dgk) from Lr that is secreted into the extracellular milieu and presumably into the intestinal lumen. DgK diminishes diacylglycerol (DAG) quantities in mammalian cells by promoting its metabolic conversion and causing reduced protein kinase C phosphorylation (pPKC) as a net effect in mammalian cells. We demonstrated that histamine synthesized by gut microbes (Lr) activates both mammalian H1R and H2R, but Lr-derived Dgk suppresses the H1R signaling pathway. Phospho-PKC and IjBa were diminished within the intestinal epithelium of mice and humans treated by wild-type (WT) Lr, but pPKC and IjBa were not decreased in treatment with DdgkA Lr. Mucosal IL-6 and systemic interleukin (IL)-1a, eotaxin, and granulocyte colony-stimulating factor (G-CSF) were suppressed in WT Lr, but not in DdgkA Lr colonized mice. Collectively, the commensal microbe Lr may act as a ''microbial antihistamine'' by suppressing intestinal H1R-mediated proinflammatory responses via diminished pPKC-mediated mammalian cell signaling.
INTRODUCTION
Diacylglycerol kinases (DGKs) are key enzymes in mammalian lipid metabolism that phosphorylate diacylglycerol (DAG) formed by the turnover of membrane phospholipids to phosphatidic acid (PA). 1, 2 Many mammalian hormones, growth factors, and other cell stimuli evoke a transient increase in the amounts of cellular DAG through hydrolysis of phosphoinositides by phospholipase C 3 upon G proteincoupled receptor (GPCR) activation. 4 As an example, when histamine binds to a G protein-coupled histamine receptor, 5 DAG is an established second messenger and an allosteric activator of protein kinase C (PKC) 4, 6, 7 for important biological processes. 3, 8 In mammals, DAG is a precursor in phospholipid metabolism, but it also serves as an intracellular lipid signal that activates PKC and is involved in cell cycle regulation, cell survival, tumorigenesis, and apoptosis. 1, 9 DGK consumes DAG to produce PA and is a potential terminator of DAG signaling. By attenuating DAG levels, DGK may downregulate membrane localization of PKC and may terminate transient receptorinduced PKC activation, thereby inhibiting signaling pathways downstream of PKC. 3 In bacteria, the head group of phosphatidylglycerol is extensively used in the biosynthesis of membrane components, and removal of the head group generates DAG. 8 DAG is converted to PA by Dgk 2 and recycles DAG into the cytidine diphosphate-diacylglycerol pathway for phospholipid synthesis, thereby preventing the lethal accumulation of DAG in bacterial membranes. 8 Lactobacillus reuteri 6475 (Lr) genome has been sequenced, 10 and this bacterial genome contains a gene encoding diacylglycerol kinase (Dgk). Grampositive bacteria have been documented to express soluble isoforms of Dgk. 8, 11 As bacterial Dgk shares 19% sequence identity with mammalian DGK, 8 we speculated that Lr-derived Dgk enzyme might inhibit DAG downstream signaling in bacterial and mammalian cells. 3, 8 A key biogenic amine, histamine, signals via type 1 histamine receptor (H1R) to affect PKC signaling in mammalian cells. Histamine serves a primary role as a mediator of allergic inflammation. 12, 13 Histamine is also a neurotransmitter that plays a key role in areas of the central nervous system enriched with histaminergic neurons such as the hippocampus. 5, 14, 15 Apart from mammals, microbes can synthesize histamine to maintain intracellular pH. 16, 17 One such bacterium, Lactobacillus reuteri 6475, belongs to the phylum Firmicutes and is indigenous to the gastrointestinal tracts of avian and mammalian species. 18 This organism is considered to be a GRAS (generally recognized as safe) and beneficial microbe, and has been used globally as a probiotic for more than two decades. A recent pangenomic study showed that Lr 6475 strain is distinctive among gut microbes by containing a complete chromosomal hdc gene cluster (genes hdcA, hdcB, and hdcP) and the genetic capacity to convert histidine to histamine. 19 Lr-derived histamine suppressed proinflammatory cytokines in intestinal epithelial cells, monocytes, 17, 20 and intestinal inflammation in different rodent models. 21, 22 However, the molecular mechanisms behind the interactions of Lr-derived histamine and the mammalian intestinal epithelium are not clearly understood.
Histamine interacts with the host using four different mammalian receptors (H1R, H2R, H3R, and H4R). 23 The majority of histamine receptors in the gut are known to be H1R and H2R. 24, 25 H1R is known to initiate proinflammatory pathways by increasing phosphorylation of protein kinase C (pPKC). 5, [26] [27] [28] H2R, in contrast, suppresses inflammation by inducing protein kinase A phosphorylation 5, 29 or by suppressing Toll-like receptor-mediated inflammation.
30 H2R antagonists increased infection risk and necrotizing enterocolitis in low birth weight infants 31, 32 and doubled the risk of hospitalization and surgery for patients with Crohn's disease. 33 Suppression of intestinal inflammation depended on the presence of dietary L-histidine and histamine-generating Lr 6475 in a murine colitis model via a H2R-mediated mechanism. 34 Histidine decarboxylase (HDC) is the unique enzyme responsible for generation of a biogenic amine, histamine, via conversion of L-histidine in mammals, including humans.
14,35 HDC deficiency in mice was shown to promote inflammation-associated colorectal cancer by accumulation of CD11b þ Gr-1 þ immature myeloid cells (IMCs) in bone marrow and spleen compared with wild-type (WT) mice. 14 This deficiency was associated with increased concentrations of proinflammatory cytokines, especially interleukin (IL)-6 and IL-1, and excessive quantities of IL-1 were generated at least partly by immature myeloid cells in the circulation. 14 Histamine plays a key role in the maturation of IMCs via HDC expression. 36 Histamine derived from Lr differentially promotes H2R pathway signaling and may antagonize H1R signaling in parallel. Microbiome-generated Dgk synthesized by Lr may interact with host epithelial DAG and inhibit H1R downstream signaling by converting DAG to PA, thereby reducing quantities of DAG, preventing PKC phosphorylation, and likely reducing intestinal inflammation. To better understand the molecular interactions of a single commensal bacterium Lr with the intestinal epithelium and its impact on shaping gut immune maturation, the mammalian intestine was colonized with WT or mutant (DhdcA or DdgkA) Lr strains deficient in diacylglycerol kinase or histamine production using inbred and outbred germ-free (GF) mouse models. The results described in this study show that bacterial DgK is secreted into the extracellular milieu and modulates PKC signaling in mouse and human intestinal epithelial cells. Furthermore, microbial DAG kinase appears to modulate myeloid cell maturation and cytokine production in vivo.
RESULTS

WT and mutant L. reuteri 6475 stably colonize the GF mouse intestine
The 10-week-old BALB/c GF mice were either colonized with L. reuteri 6475 WT (WT) or DhdcA L. reuteri 6475 (DhdcA) or DdgkA L. reuteri 6475 (DdgkA) on day 1 and maintained for 22 days (Figure 1a) . On day 23, the mice were killed and intestinal contents were collected and processed as described. Extracted DNA was quantified using quantitative PCR. GF mice colonized for 22 days with WT or DhdcA or DdgkA Lr were successfully colonized with a single Lr administration. We detected log 10 8.56 ± 0.72 of WT Lr, log 10 7.64 ± 0.76 of DhdcA, and log 10 7.06 ± 0.66 of DdgkA per gram wet weight of cecum contents of BALB/c gnotobiotic mice (Figure 1b) . Similarly, 13-week-old Swiss Webster (SW) GF mice were stably colonized with L. reuteri 6475 WT (WT) for 22 days (Supplementary Figure S1a online). However, SW GF mice yielded more abundant gut lactobacilli following colonization by Lr compared with BALB/c GF mice. On day 23, the SW mice were killed, and were colonized with log 10 9.83 ± 0.24 of WT Lr per gram of cecal contents (Supplementary Figure S1b) .
Systemic immune responses were suppressed by intestinal colonization with histamine-generating, DAG kinase-producing WT L. reuteri
To identify whether hdcA þ dgkA þ Lr colonization had an impact on immunomodulation of the mouse intestine, proinflammatory cytokines including IL-1a, IL-6, tumor necrosis factor-a, IL-17, IL-22, IL-12, eotaxin, granulocyte colony-stimulating factor (G-CSF), and interferon-g were analyzed in the blood plasma of gnotobiotic and GF control mice. Interestingly, mice colonized with WT L. reuteri yielded reduced circulating concentrations of IL-1a compared with mice colonized by L. reuteri DdgkA or control GF mice (Figure 2a ). Similar differences were observed for the chemokines, eotaxin and G-CSF, in peripheral blood quantified in BALB/c gnotobiotic mice colonized by WT L. reuteri and respective mutants (Figure 2b,c) . In addition, circulating quantities of IL-6 were reduced in SW (outbred) mice that received WT L. reuteri (Supplementary Figure S2e) by orogastric gavage. In addition, amounts of plasma IL-10, a cytokine known to suppress inflammation, were increased in mice colonized by WT L. reuteri (Supplementary Figure S2f) , whereas G-CSF and IL-6 were diminished (Supplementary Figure S2a Intestinal mucosal proinflammatory cytokine suppression
Mucosal immune responses because of the presence and absence of histamine and/or diacylglycerol kinase of WT L. reuteri 6475 were measured in intestinal mucosal tissue samples. Cecal IL-6 mRNA in the mucosa was significantly decreased in mice colonized by WT L. reuteri as compared with mice colonized by mutant DdgkA L. reuteri or control GF BALB/c mice ( Figure 2d ). However, other cytokine mRNAs such as tumor necrosis factor-a, interferon-g, IL-17, IL-12, IL-1a, and IL-22 were not altered or below the detection limit. Similarly, IL-6 mRNA and protein quantities were significantly Colonization by WT dgkA þ , but not mutant DdgkA, L. reuteri inhibits mucosal PKC phosphorylation and NF-jB accumulation in intestinal epithelium
As PKC phosphorylation depends on availability of DAG through GPCR activation, 5 phosphorylation of pPKC was compared among the cecal mucosae of mice colonized by WT and mutant DhdcA or DdgkA L. reuteri, in addition to control GF mice. To determine that the bacterial enzyme Dgk, presumably released into the extracellular milieu, inhibits DAG-mediated signaling and PKC phosphorylation in mammalian cells, immunoblot studies were performed targeting PKC phosphorylation using specific antibodies. The phosphorylated protein kinase pPKCa (Ser 657) was diminished in the cecal mucosa of gnotobiotic BALB/c mice colonized with WT Lr compared with control GF mice. In addition, BALB/c mice colonized by mutant DhdcA L. reuteri had reduced amounts of pPKC when compared with control GF mice ( Figure 3a) . Interestingly, the greatest abundance of pPKC was localized in the intestines of mice colonized by mutant DdgkA L. reuteri as compared with GF mice colonized by WT L. reuteri or mutant DhdcA L. reuteri (Figure 3a,c) . Consistent with the immunoblot data, pPKC was decreased in ceca of mice colonized by WT and mutant DhdcA L. reuteri when compared with mice colonized by mutant DdgkA L. reuteri ( Figure 3b ) evaluated by fluorescence immunohistochemistry. SW GF mice colonized by WT L. reuteri also showed reduced levels of pPKC compared with corresponding nonphosphorylated PKC and GF PKC protein concentrations from the cecal mucosa (Supplementary Figure S3a) .
Human jejunal enteroids treated with WT L. reuteri conditioned media (CM) showed decreased pPKC levels compared with human enteroids treated with mutant DdgkA L. reuteri CM (Supplementary Figure S4a) . In addition, DhdcA Lr CM-treated enteroids showed a trend toward increased PKC phosphorylation (Supplementary Figure S4a) . Consistent with immunoblot data, pPKC was decreased in human enteroids treated with WT L. reuteri CM compared with mutant DdgkA Lr CM, as examined by fluorescence immunohistochemistry (Supplementary Figure S4b) . To explore mammalian intestinal epithelial DAG and pPKC signaling further, ileal enteroids from 10-week-old GF mice were treated with a DGK inhibitor in vitro. The enteroids treated with a DGK inhibitor (R59-022) yielded increased PKC phosphorylation in the presence of WT Lr CM, whereas enteroids lacking DGK inhibitor in the presence of WT Lr CM did not yield evidence of increase PKC phosphorylation (Supplementary Figure S5) . Similarly, in vitro treatment of HT-29 human epithelial cells with DdgkA Lr CM yielded a nearly threefold increase in PKC phosphorylation compared with treatment with Lr WT CM (Supplementary Figure S4c) . In addition, nonphosphorylated (2) protein pooled from all the five male mice per group. The proteins were normalized for housekeeping protein atubulin. The pPKC and PKC ratio was obtained by imageJ analysis where pPKC and PKC from GF control mice was set to 1 and used as baseline. Then, 25 mg of proteins were loaded into each wells of the sodium dodecyl sulfate (SDS) gel. Proteins were isolated from the pooled samples (1 to 5 ¼ 1 and 6 to 10 ¼ 2) 3 individual times and proteins were estimated by Bio-Rad analysis and western blot was performed for 3 individual times. Figure S4c) .
Activation and accumulation of cytosolic nuclear factor (NF)-kB (IkBa-RelA:P50 complex) is dependent on phosphorylation of pPKC. 37 The intestinal epithelial tissues obtained from the cecal mucosa of mice colonized by WT, mutant DhdcA, or DdgkA L. reuteri were compared with control GF mice. To determine that the bacterial enzyme Dgk inhibits activation of NF-kB through reduced phosphorylation of PKC in mammalian cells, immunoblot studies were performed targeting NF-kB accumulation using specific antibodies. Total IkBa (L35A5) complex was diminished in the cecal mucosa of gnotobiotic BALB/c mice colonized with WT Lr as compared with control GF mice. The DdgkA L. reuteri colonized mice yielded increased synthesis of NF-kB (Figure 3d ).
L. reuteri DAG kinase is secreted into the extracellular milieu
As we observed negligible PKC phosphorylation in intestinal mucosal tissues of mice colonized with WT or DhdcA compared with DdgkA Lr, Dgk (B15 kDa) 11, 38 is secreted by the bacterium Lr, and the extracellular microbial enzyme may effectively decrease DAG activity in mammalian cells. By suppressing DAG lipid-mediated signaling, DAG kinase from lactobacilli may suppress H1R signaling via reduced PKC phosphorylation. To explore the possibility that bacterial Dgk may be secreted into the intestinal lumen and interact with substrate DAG in the host epithelium, Dgk was detected in bacterial culture supernatants following growth in liquid media. WT and mutant hdcA or DdgkA L. reuteri 6475 were cultured in LDM4 for 12 h in the presence and absence of DAG, and liquid culture supernatants were evaluated. Extracellular proteins were fractionated by size, processed for tryptic digestion, and analyzed by liquid chromatography/ tandem-mass spectrometry followed by amino acid sequence analysis. Amino acid sequences of Dgk peptide fragments (Supplementary Figure S6) matched the expected Dgk protein sequences (Figure 4a-c) . As expected, Dgk was present in WT L. reuteri supernatants, but absent in mutant DdgkA L. reuteri cultures (Figure 4c) . WT Lr dgkA mRNA levels were significantly increased in the presence of DAG compared with absence of DAG in the growth medium after 12 h in vitro ( Figure 4d ) and bacterial dgkA gene expression was increased in cecal luminal contents of the gnotobiotic BALB/c mouse intestine colonized by WT L. reuteri (Figure 4f ). In addition, clade II L. reuteri 6475 dgkA gene was present in greatest quantities during the elongation phase (Supplementary Figure  S7) . Bacterial mRNA was obtained from the cecal contents and quantified using reverse transcriptase-PCR. Bacterial dgkA expression was increased in the lumens of both WT and DhdcA Lr colonized gnotobiotic BALB/c mice compared with DdgkA Lr colonized mice, whereas GF control BALB/c mice showed no evidence of dgkA expression (Figure 4f ). In addition, mammalian DGK quantified from the cecal intestinal epithelium by immunoblot did not yield significant differences between control mice and the GF mice colonized with WT or mutant L. reuteri (Supplementary Figure S3b) .
Bacterial histidine decarboxylase mRNA and luminal histamine present in the intestinal lumen of gnotobiotic BALB/c mice colonized by L reuteri
Luminal contents were treated with 99% methanol and the supernatants obtained were used for histamine quantification using liquid chromatography/mass spectrometry. Table  S1 ). However, mutant DhdcA Lr lacked detectable histamine in culture supernatants (Supplementary Table S1 ). Bacterial histidine decarboxylase mRNA, presumably at least partly from L. reuteri, was also detectable in the intestinal lumens of gnotobiotic BALB/c mice colonized by WT and mutant DdgkA L. reuteri (Figure 4e ).
L. reuteri resides adjacent to the intestinal epithelium and modifies the intestinal mucus layer and GPCR signal of gnotobiotic mice
Bacterial fluorescent in situ hybridization demonstrated that Lr resides in the mucus layer, penetrates the inner mucus layer, and establishes intimate contact with intestinal enterocytes in the murine large intestine (Figure 5a-f) . The data suggest that Lr directly communicates with the host intestinal epithelium irrespective of WT or mutant (hdcA, dgkA) status. Similarly, Lr was adjacent to the human epithelium when Lr was co-cultured with human jejunal enteroid monolayers (Figure 5g,h ) and HT-29 cells (Figure 1c) .
To determine H1R and H2R GPCR protein quantities, fluorescence immunohistochemistry analysis was performed as described in the Methods. Both H1R and H2R protein expression were similar between the WT, DhdcA, and DdgkA Lr colonized mice compared with control GF mice ( Figure  5i-p) . However, H1R was present in greater abundance than H2R in the intestinal epithelium.
Mucus serves as the primary contact between the intestinal epithelial layer and luminal antigens. 39, 40 As GF mice were colonized with Lr, it was of interest to evaluate mucus maturation after probiotic colonization using lectin staining. We observed significantly increased mucus fucosylation with Ulex europaeus agglutinin staining of the terminal mucus fucose in WT Lr colonized compared with control BALB/c GF mice (Supplementary Figure S8ai and aii) . Similarly, increased fucosylation was observed in mice colonized with DhdcA and DdgkA Lr compared with control BALB/c GF mice. However, DdgkA colonized mice had decreased mucus fucosylation compared with WT Lr colonized mice (Supplementary Figure S8ai-aiv) . Similarly, SW mice colonized with WT Lr also showed increased mucus fucosylation with increased Figure  S8av-aviii and 8b ).
mucus secreting goblet cells (Supplementary
Histamine-dependent enhancement of CD11b
þ Gr-1 þ Ly6G high splenic myeloid cell maturation was offset by the absence of DAG kinase in L. reuteri
To determine whether bacterial-derived histamine has immunomodulatory effects by targeting myeloid cell maturation, GF mice were colonized with WT, DhdcA, DdgkA Lr, and a control group without any bacteria. The absence of endogenous histamine results in increased proportions of IMCs and has been associated with cancer progression in mammals. 14 Azoxymethane/dextran sodium sulfate-treated Hdc -/-male mice showed significantly reduced CD11b þ Gr-1 þ IMCs (80%) in spleens after oral administration of hdc þ Lr 6475 (WT) treatment. 41 In this study, BALB/c gnotobiotic mice colonized with WT L. reuteri strain yielded significantly decreased proportions of CD11b þ Gr-1 þ IMCs in the spleen (Figure 6b) , suggesting that histamine-generating Lr promotes maturation of splenic CD11b þ Gr-1 þ IMCs (Figure 6a,b) . The lack of bacterial histidine decarboxylase in DhdcA Lr corresponded with a trend toward increased populations of IMCs in the spleen (Figure 6b) . In addition, GF mice colonized with DdgkA Lr did not result in suppression of IMCs in the spleen (Figure 6b) , suggesting that loss of microbiome-derived DAG kinase and enhanced H1R signaling may offset effects via H2R on myeloid cell maturation. In addition, we observed reduced Ly6G high and Ly6G medium populations in the spleens of mice that were colonized with WT L. reuteri as compared with mice colonized by mutant DhdcA or DdgkA L. reuteri (Figure 6a ).
L. reuteri colonization leads to increased microRNA mmumiR-669k-3p in the intestinal epithelium of GF BALB/c mice Because basal cytokine responses were suppressed in the presence of WT L. reuteri in the intestines of gnotobiotic BALB/ c mice (Figure 2) , changes in inflammatory responses were related to microRNA modification. A total of 84 individual microRNAs considered as candidates for regulating inflammatory pathways were selected. The microRNA expression patterns in the intestinal mucosa were evaluated for alterations by Lr-derived histamine and/or Dgk. The miRNA mmu-miR-669k-3p was found to be increased by twofold in mice colonized with WT Lr compared with DhdcA, DdgkA Lr, and control GF mice (Figure 6d ).
DISCUSSION
The mammalian microbiome contains microbial cells with genomes encoding the capacity for microbial-mediated conversion of amino acids to bioactive signals such as biogenic amines. 17 As shown in this study, bacterial enzymes such as diacylglycerol kinase may abrogate mammalian cell signaling pathways by effectively ''removing'' mammalian lipid signals such as diacylglycerol. The gut commensal microbe, L. reuteri, secretes Dgk and because of its close proximity to the gut epithelium, this enzyme may convert mammalian DAG to PA. The presence of dgkA-producing L. reuteri suppresses phosphorylation of PKC downstream of the histamine type 1 receptor. Dgk secreted by Lr 6475 potentially interacts with epithelial DAG lipid signaling, thereby inhibiting proinflammatory H1R and allowing ''net positive'' activation of H2R by histamine-generating Lr. Ultimately, this reduced phosphorylation of PKC may result in diminished signaling via NF-kB and suppression of mucosal inflammation.
Human-derived clade II L. reuteri strains contain a complete chromosomal hdc gene cluster with genes encoding histidine decarboxylase (HdcA) and the histidine/histamine transporter (HdcP), 19 culminating in suppression of human tumor necrosis factor production. 17 Gut microbes like L. reuteri clade II strains provide a useful model system to study the effects of luminal histamine on the mammalian gut mucosa. By introducing individual gut microbes into GF mice, our data show that WT and mutant L. reuteri each colonized the mammalian intestine successfully with a single oral dosing. Although immunologists have accumulated insights regarding how histamine works in allergic inflammation 42 and in the context of mucosal mast cells, 12 the role of histamine in the lumen of the gastrointestinal tract is not well understood. The effects of luminal histamine may differ from that of mucosal histamine simply based on the relative distributions of histamine receptors in different cell types. Our studies suggest that luminal histamine does affect mucosal and systemic immunity, as well as mammalian epithelial cell signaling pathways. Suppression of IL-6 production within the cecal mucosa is one example of histaminedependent suppression of gut inflammation in an acute colitis model. 34 By investigating the role of luminal histamine produced by gut microbes, we may gain a deeper mechanistic understanding of the interrelationships between the gut microbiome, the intestinal mucosa, and immunity.
Luminal histamine may act through the histamine type 2 receptors (to suppress the production of proinflammatory cytokines 30 and cell signaling via mitogen-activated protein kinases (see Thomas et al. 17 and Gao et al. 34 ). However, both H1R and H2R are present in the mouse and human intestinal epithelium, and hence the role of H1R in promoting gastrointestinal mucosal inflammation must be considered. 5 Our studies provide insights into a potential ''brake'' directed at H1R-mediated signaling. A bacterial enzyme, Dgk, may modify the lipid signal diacylglycerol to abrogate H1 receptor-mediated signaling via PKC. In contrast, histamine binding to H2R activates protein kinase A and binds cAMP via adenylate cyclase 43 to suppress mitogen-activated protein kinase activation. Instead, H1R signaling involves the conversion of phosphatidylinositol 2 by phospholipase C into DAG and inositol triphosphate. 25, 43, 44 DAG stimulates phosphorylation of PKC 5, 23, 44 by binding to the catalytic domain 1 and recruiting PKC to the membrane. The interaction of PKC with the membrane causes release of pseudosubstrate from the catalytic domain leading to availability of serine and threonine phosphoacceptor residues causing PKC activation. 45 Phosphorylated PKCa (pPKC) is known to induce proinflammatory responses such as NF-kB activation. 43, 46 Thus, a net reduction of pPKC in the intestinal mucosa by the gut microbiome may help to keep the immune system ''in check'' and promote immunologic homeostasis.
Beneficial microbes in the intestine may produce enzymes that inhibit mammalian cell signaling pathways by effective signal depletion. DGK is an enzyme known to inhibit DAGmediated signaling by converting DAG to (PA utilizing adenosine triphosphate as the phosphate source.
3,47-49 Conversion of DAG to PA depletes DAG, and this reduced amount of DAG may suppress PKC activity, 47, 49 thereby suppressing proinflammatory immune responses in the intestine (Figure 7) . On that note, Escherichia coli has increased amounts of DAG kinase. Resting human platelets (10 9 cells have 0.111 nmol DAG) treated with E. coli DAG kinase results in conversion of lipid DAG to PA. 50 We propose that the mammalian microbiome may synthesize Dgk adjacent to the intestinal epithelium, effectively depleting mammalian DAG and inhibiting H1R downstream activation. In support of our proposed hypothesis, L. reuteri is positioned adjacent to the intestinal epithelium and could deliver DAG kinase in close proximity to the epithelial cell membranes. PKC phosphorylation was drastically reduced in the intestinal epithelium of WT compared with DdgkA Lr colonized mice. Dramatically increased phosphorylation of PKC was evident in the intestinal mucosa of mice colonized by DdgkA Lr and control GF BALB/c mice, but not in mice colonized by WT or DhdcA L. reuteri. Increased PKC phosphorylation was observed in human cells such as the human intestinal epithelial cell line HT29 treated with DdgkA Lr-CM. These findings raise intriguing possibilities of bacterial enzymes from the mammalian microbiome converting compounds within the mammalian cell milieu and altering signaling pathways in mammalian cells. Mammalian epithelial cells may, for brief periods of time, behave like ''chimeric'' cells with bacterial and mammalian enzymes affecting intra-mammalian cell signaling pathways.
Previous findings showed that bacterial Dgk shares 18 to 19% amino acid sequence identity with human DGK 8 that can have soluble isoforms. 8, 11, 38 Similarly, Staphylococcus aureus DAG kinase B structure has been identified to be directly relevant to the human enzymes that function in cell signaling because the key structural and active site residues are conserved in the sequences of both enzymes. 8 The bacterial Dgk superfamily provides candidate enzymes and substrates for evaluation of small-molecule therapeutics to combat Gram-positive organisms and to modulate lipid signaling pathways in humans. 8 Mammalian DGK is found both in soluble and membranebound forms actively converting lipid DAG to PA, 51 thereby suppressing PKC phosphorylation via DAG phosphorylation to PA. 52 We hypothesized that Dgk released by Dgk-positive intestinal lactobacilli can suppress H1R downstream signaling by modifying mammalian cell membrane-associated DAG. It is not understood whether a bacterial kinase from the microbiome may directly convert membrane-associated DAG in adjacent mammalian epithelial cells. We present evidence that downstream mammalian PKC is activated in the absence of gut microbes, but suppressed in the presence of histamine-generating microbes with an intact DAG kinase gene. In support of the hypothesis, Lrderived Dgk could not suppress intestinal epithelial PKC phosphorylation in the presence of a DGK inhibitor.
Prior evidence indicates that bacterial DAG kinase may be secreted or released by microbes into the extracellular milieu. 8, 50 Prior studies have also indicated that mammalian DAG kinases may be released; 51 however, mammalian DAG kinase was not significantly altered by the presence of L. reuteri DAG kinase in gnotobiotic mice. DAG kinases bind to lipid DAG and generate PA in the lipid bilayer and these compounds may be available for effects on intracellular signaling pathways. Bacillus subtilis has been shown to produce 34 kDa soluble Dgk enzyme. 11 We looked for soluble Dgk proteins/peptides in the supernatant obtained from WT Lr culture for 12 h in LDM4. By liquid chromatography/tandem-mass spectrometry analysis we generated the presence of six peptide sequences from bacterial culture supernatants, and these peptide sequences were identical to segments of the Dgk protein (http:// www.ncbi.nlm.nih.gov/protein/EGC15283.1) from Lr 6475. In addition, Lr 6475 was found to colonize the germ-free mouse intestine, adjacent to the intestinal epithelium. L. reuteri is known to both possess secretory and extracellular proteins (secretome) and these secreted proteins include enzymes involved in lipid metabolism. 53, 54 DAG is a well-known mammalian membrane lipid compound that flip-flops rapidly in the lipid bilayer. 55 Dgk secreted by L. reuteri may interact with host DAG in the gut epithelium, reducing amounts of DAG and thereby restricting PKC phosphorylation and NF-kB activation 37 following downregulation of mucosal cytokines like IL-6. Such a reduction in mucosal inflammation or dampening of mucosal immunity may result in altered maturation programs of splenic myeloid cells. 14 A deficiency HDC and lack of endogenous histamine was shown to promote inflammation-associated colorectal cancer by accumulation of CD11b þ Gr-1 þ IMCs. 14, 56 Modulation of histamine receptors through its antagonist modifies colorectal cancer progression. [57] [58] [59] We observed suppression of splenic (not bone marrow) IMCs in germ-free mice colonized with WT L. reuteri. This suppression could be due to reduced IL-6 expression in intestinal mucosa because increased IL-6 was previously shown to increase splenic IMC infiltration. 14, 60 Suppression of IL-6 facilitates maturation of IMCs.
14,36 However, DdgkA Lr colonized mice did not suppress splenic IMCs or reduce IL-6 mRNA expression, suggesting that dgkA is important in alteration of H1R-mediated signaling and maturation of myeloid cells in peripheral compartments. Bacterial genes hdcA and dgkA are important for L. reuteri to generate sustained immunosuppressive effects in the intestine. In addition to reduced IL-6 gene levels we also observed reduced IL-1a in blood plasma of mice that received WT L. reuteri compared with the GF control mice. Interestingly, DdgkA Lr colonized mice had increased levels of plasma IL-1a, a proinflammatory cytokine predominantly secreted by macrophages. 61 IL-1a may promote IL-6 production. 62 As we observed decreased IL-1a protein levels in blood plasma of WT Lr colonized mice but not in DhdcA and DdgkA Lr colonized mice, we speculate that luminal histamine and luminal DAG kinase may both be important for IL-1a production by mucosal macrophages. Furthermore, we observed diminished mucosal IL-6 mRNA levels in the presence of WT Lr 6475 with increase in microRNA (mmu-miR)-669k-3p of BALB/c mice. Therefore, we speculate that mmu-miR-669k-3p expression modulates IL-6 gene expression and may have an impact on myeloid cell maturation. However, detailed studies are required to further characterize the microRNA mmu-miR-669k-3p on intestinal immunomodulation.
The mammalian microbiome includes dozens of bacterial taxa that possess the genetic capacity to perform intestinal luminal conversion of diverse biological compounds. These compounds may be derived from the diet or mammalian cells and provide substrates for bacterial enzymes. The model commensal microbe, L. reuteri, has yielded insights regarding luminal conversion by gut microbes and effects on epithelial and immune cell signaling pathways. Gut lactobacilli may generate small amines like histamine from amino acids and suppress inflammation via specific receptors. Gut microbes may also provide enzymes that convert lipid signals, thereby resulting in diminished signaling via receptors that promote allergic inflammation. The net effect is suppression of intestinal inflammation. Future advances in microbiome science may lead to new therapeutics that target bacterial enzymes acting in bacterial cells or mammalian cells (or both cell types) to alter cell signal or immune responses. Probiotics generating ''microbial antihistamine factors'' like DAG kinase may abrogate intestinal inflammation and promote the development of new microbiome-harvested treatment strategies.
METHODS
Bacterial strains. The bacterial strains used in this study were: L. reuteri 6475 (or also known as MM4-1A), DhdcA Lr 6475, and DdgkA Lr 6475. All strains were routinely cultured at 37 1C in MRS (Man, Rogosa, and Sharpe) or LDM4 media and incubated overnight under strictly anoxic conditions using N 2 /CO 2 (80:20; v/v) as the gas phase. Immunoblot studies of pPKC signaling. Proteins were extracted from tissue samples in RIPA buffer. A total of 30 or 20 mg of protein from each sample was separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes. Membranes were incubated with specific primary antibodies, nonphosphorylated PKC 63 and pPKCa (Ser 657) (diluted 1:1,000) (Santa Cruz Biotechnology, Santa Cruz, CA).
Statistics. Data were tested for normal distribution using the Kolmogorov-Smirnov test. Normally distributed data are presented as means with s.e., whereas the medians with their range are given for nonnormally distributed data. Significance of differences between Control, WT Lr, DhdcA, and DdgkA mutant Lr colonized BALB/c mice were analyzed using the one-way analysis of variance test for normally distributed data (or) the Kruskal-Wallis test for nonnormally distributed data, followed by either Bonferroni/Tukey or Dunn's comparison post hoc tests. Differences between with and without DAG-treated bacterial culture gene expression and SW mice with and without WT Lr were analyzed using Student's t-test followed by the Mann-Whitney test for nonnormally distributed data. Differences between the groups were considered significant at *Po0.05, **Po0.01, and ***Po0.001. SPSS 16.0 (IBM, Armonk, NY) for Windows 7 was used for data analysis. Prism 5.0 software (Graph Pad Software, La Jolla, CA) for Windows was used for data presentation and also for data analysis.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
